Consolidated statement of financial position / ASSETS
Download(XLS, 46 KB)| as of December 31, € in millions | Note | 2023 | 2022 |
|---|---|---|---|
| Cash and cash equivalents | 15 | 2,562 | 2,749 |
| Trade accounts and other receivables, less allowances for expected credit losses |
16 | 3,673 | 7,161 |
| Inventories | 17 | 2,517 | 4,833 |
| Other current assets | 18 | 3,213 | 3,536 |
| Assets held for sale | 555 | – | |
| I. Total current assets | 12,520 | 18,279 | |
| Property, plant and equipment | 19 | 8,964 | 12,919 |
| Right-of-use assets | 32 | 1,818 | 5,922 |
| Goodwill | 20 | 15,089 | 31,490 |
| Other intangible assets | 20 | 2,531 | 4,338 |
| Fresenius Medical Care investment accounted for using the equity method | 21 | 3,500 | n.a. |
| Other non-current assets | 18 | 502 | 2,621 |
| Deferred taxes | 11 | 360 | 831 |
| II. Total non-current assets | 32,764 | 58,121 | |
| Total assets | 45,284 | 76,400 |
Consolidated statement of financial position / LIABILITIES AND SHAREHOLDERS’ EQUITY
Download(XLS, 47 KB)| as of December 31, € in millions | Note | 2023 | 2022 |
|---|---|---|---|
| Trade accounts payable | 1,488 | 2,164 | |
| Short-term provisions and other short-term liabilities | 22, 23 | 4,920 | 8,242 |
| Short-term debt | 24 | 569 | 867 |
| Current portion of long-term debt | 24 | 492 | 669 |
| Current portion of lease liabilities | 32 | 206 | 851 |
| Current portion of bonds | 25 | 815 | 649 |
| Current portion of convertible bonds | 26 | 499 | – |
| Short-term liabilities for income taxes | 111 | 216 | |
| Liabilities directly associated with the assets held for sale | 230 | – | |
| A. Total short-term liabilities | 9,330 | 13,658 | |
| Long-term debt, less current portion | 24 | 2,216 | 2,166 |
| Lease liabilities, less current portion | 32 | 1,792 | 5,741 |
| Bonds, less current portion | 25 | 9,241 | 16,329 |
| Convertible bonds | 26 | – | 491 |
| Long-term provisions and other long-term liabilities | 22, 23 | 1,578 | 2,802 |
| Pension liabilities | 27 | 666 | 1,099 |
| Long-term liabilities for income taxes | 279 | 242 | |
| Deferred taxes | 11 | 531 | 1,654 |
| B. Total long-term liabilities | 16,303 | 30,524 | |
| I. Total liabilities | 25,633 | 44,182 | |
| A. Noncontrolling interests | 28 | 652 | 11,803 |
| Subscribed capital | 29 | 563 | 563 |
| Capital reserve | 29 | 4,326 | 4,323 |
| Other reserves | 29 | 14,092 | 15,122 |
| Accumulated other comprehensive income | 30 | 18 | 407 |
| B. Total Fresenius SE & Co. KGaA shareholders’ equity | 18,999 | 20,415 | |
| II. Total shareholders’ equity | 19,651 | 32,218 | |
| Total liabilities and shareholders’ equity | 45,284 | 76,400 | |
| The following notes are an integral part of the consolidated financial statements. | |||
Contact
Fresenius SE & Co. KGaA
Investor Relations
+49 (0) 6172 608-2485
ir-fre@fresenius.com